doctor head
  pharmacy and drugs  
search Search
       About us       News      A-Z Drugs      Stores      Top Drugs      Contact  
  doctor doctor hand
  doctor legs  


Subscribe to our newsletter:
    Search results
Search results for: ateral

1 - 5 of 8 <<previous | next>>

Drugs results:

Losartan tablets


Losartan belongs to a class of drug known as angiotension II receptor antagonists, which directly blocks the angiotensin II (a potent vasoconstrictor). This drug prevents the constriction (narrowing) of blood vessels (veins and arteries). I more...

Diseases results:

High blood pressure
Migraine headaches
Muscle pain

Articles results:

Expert Critique Says FDA Does Not Adequately Protect Consumers From Unsafe Drugs, Calls For Agency Changes
FDA-mandated studies on prescription drugs can miss serious safety issues before and after a drug's approval, according to five current and former members of the agency's Drug Safety and Risk Management Advisory Committee, the

Closer Ties On Medicines Safety Between EU And Japan
The European Union and Japan will from now on be able to exchange confidential information about the authorisation and safety of medicines.Confidentiality arrangements were agreed between the European Commission and the European Medicines Agency (EMEA) on the one side and the Japanese Ministry of Health, Labour and Welfare (MHLW) and Japanese Pharmaceuticals and Medical Devices Agency (PMDA) on the other at a bilateral meeting in Tokyo.

Scope For NHS To Create Substantial New Value For Patients, Says ABPI Director General, UK
With a challenging Comprehensive Spending Review (CSR) currently being finalised, the ABPI Director General, Dr Richard Barker, today said that, by new value-for-money initiatives, up to ?£3billion could be made available for reinvestment in patient care for the NHS by the end of the CSR period. The speech to the 13th annual Economist pharmaceuticals conference outlined a new approach to delivering and measuring value in the NHS, focused on patient outcomes.

Abbott's Decision To Withhold New Drug Applications In Thailand 'Strikes At Heart' Of Country's Efforts To Provide Wider Drug Access, Editorial Says
The decision by pharmaceutical company Abbott Laboratories to withdraw applications to sell new drugs in Thailand "certainly strikes at the heart of the government's efforts to secure life-saving medicine for all Thais," a Bangkok Post editorial says (Bangkok Post, 3/22).

New Trade Agreement Language To Allow Developing Countries More Flexibility In Circumventing Drug Patents, Other Restrictions
Democratic lawmakers and U.S. trade officials are in the final stages of negotiation over language to be added to international free trade agreements that would allow developing countries more flexibility in circumventing drug patents and other restrictions on pharmaceuticals, sources said recently, CongressDaily reports.

1 - 5 of 8 <<previous | next>>

© 2006-2010 All rights reserved.